Mara Ardine

708 total citations
19 papers, 371 citations indexed

About

Mara Ardine is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Mara Ardine has authored 19 papers receiving a total of 371 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 5 papers in Cancer Research and 3 papers in Molecular Biology. Recurrent topics in Mara Ardine's work include HER2/EGFR in Cancer Research (6 papers), Cancer Treatment and Pharmacology (5 papers) and Bone health and treatments (4 papers). Mara Ardine is often cited by papers focused on HER2/EGFR in Cancer Research (6 papers), Cancer Treatment and Pharmacology (5 papers) and Bone health and treatments (4 papers). Mara Ardine collaborates with scholars based in Italy, United Kingdom and Canada. Mara Ardine's co-authors include Michela Donadio, Matteo Scoletta, L. Ciuffreda, Marco Mozzati, Alfredo Berruti, Anna Maria Vandone, Alberto Bottini, Daniele Generali, Vito Amoroso and Lucia Vassalli and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and British Journal of Cancer.

In The Last Decade

Mara Ardine

19 papers receiving 365 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mara Ardine Italy 11 285 127 83 83 52 19 371
L. Ciuffreda Italy 8 208 0.7× 119 0.9× 52 0.6× 74 0.9× 96 1.8× 23 333
Laura Yébenes Spain 11 134 0.5× 55 0.4× 93 1.1× 75 0.9× 72 1.4× 24 347
Georgia Litsas United States 6 275 1.0× 113 0.9× 135 1.6× 48 0.6× 27 0.5× 11 360
Alberto Dalla Volta Italy 10 102 0.4× 69 0.5× 93 1.1× 94 1.1× 47 0.9× 37 321
Nilesh Mehta United States 5 319 1.1× 71 0.6× 100 1.2× 27 0.3× 82 1.6× 6 389
Yukinori Ozaki Japan 11 295 1.0× 26 0.2× 102 1.2× 66 0.8× 62 1.2× 51 385
Jean-Jacques Body Belgium 7 299 1.0× 167 1.3× 84 1.0× 21 0.3× 100 1.9× 17 411
Anne Sophie Sølling Denmark 10 306 1.1× 226 1.8× 20 0.2× 32 0.4× 205 3.9× 18 436
Shinya Maita Japan 10 137 0.5× 22 0.2× 146 1.8× 48 0.6× 109 2.1× 25 370
Victoria Woo United States 12 437 1.5× 260 2.0× 102 1.2× 12 0.1× 60 1.2× 21 616

Countries citing papers authored by Mara Ardine

Since Specialization
Citations

This map shows the geographic impact of Mara Ardine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mara Ardine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mara Ardine more than expected).

Fields of papers citing papers by Mara Ardine

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mara Ardine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mara Ardine. The network helps show where Mara Ardine may publish in the future.

Co-authorship network of co-authors of Mara Ardine

This figure shows the co-authorship network connecting the top 25 collaborators of Mara Ardine. A scholar is included among the top collaborators of Mara Ardine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mara Ardine. Mara Ardine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Pedersini, Rebecca, Sara Bosio, Bárbara Zanini, et al.. (2021). Changes in eating habits and food preferences in breast cancer patients undergoing adjuvant chemotherapy. Scientific Reports. 11(1). 12975–12975. 15 indexed citations
2.
Pedersini, Rebecca, Fabio Gallo, Filippo Maffezzoni, et al.. (2020). The Interaction of Lean Body Mass With Fat Body Mass Is Associated With Vertebral Fracture Prevalence in Women With Early Breast Cancer Undergoing Aromatase Inhibitor Therapy. JBMR Plus. 5(2). e10440–e10440. 19 indexed citations
3.
Pedersini, Rebecca, Vito Amoroso, Maria Chiara Parati, et al.. (2020). Efficacy of Eribulin mesylate in older patients with breast cancer: A pooled analysis of clinical trial and real-world data. Journal of Geriatric Oncology. 11(6). 976–981. 4 indexed citations
4.
Pedersini, Rebecca, Susanna Bianchi, Lucia Vassalli, et al.. (2020). Efficacy of the DigniCap System in preventing chemotherapy‐induced alopecia in breast cancer patients is not related to patient characteristics or side effects of the device. International Journal of Nursing Practice. 27(3). e12888–e12888. 7 indexed citations
5.
Pedersini, Rebecca, Vito Amoroso, Filippo Maffezzoni, et al.. (2019). Association of Fat Body Mass With Vertebral Fractures in Postmenopausal Women With Early Breast Cancer Undergoing Adjuvant Aromatase Inhibitor Therapy. JAMA Network Open. 2(9). e1911080–e1911080. 31 indexed citations
6.
Generali, Daniele, Mara Ardine, Carla Strina, et al.. (2015). Neoadjuvant Treatment Approach: The Rosetta Stone for Breast Cancer?. JNCI Monographs. 2015(51). 32–35. 6 indexed citations
7.
Generali, Daniele, Alfredo Berruti, Laura Zanotti, et al.. (2015). Effect of Primary Letrozole Treatment on Tumor Expression of mTOR and HIF-1  and Relation to Clinical Response. JNCI Monographs. 2015(51). 64–66. 6 indexed citations
8.
Koukourakis, Michael I., Alexandra Giatromanolaki, Alberto Bottini, et al.. (2014). Prospective neoadjuvant analysis of PET imaging and mechanisms of resistance to Trastuzumab shows role of HIF1 and autophagy. British Journal of Cancer. 110(9). 2209–2216. 18 indexed citations
9.
Righi, Luisella, Simona Vatrano, Susanna Cappia, et al.. (2013). Detection and characterization of classical and “uncommon” exon 19 Epidermal Growth Factor Receptor mutations in lung cancer by pyrosequencing. BMC Cancer. 13(1). 114–114. 12 indexed citations
10.
Petrelli, Fausto, Andrea Coinu, Mary Cabiddu, et al.. (2013). Platinum rechallenge in patients with advanced NSCLC: A pooled analysis. Lung Cancer. 81(3). 337–342. 25 indexed citations
11.
Vandone, Anna Maria, Michela Donadio, Marco Mozzati, et al.. (2011). Impact of dental care in the prevention of bisphosphonate-associated osteonecrosis of the jaw: a single-center clinical experience. Annals of Oncology. 23(1). 193–200. 114 indexed citations
12.
Berruti, Alfredo, Maria Pia Brizzi, Daniele Generali, et al.. (2008). Presurgical Systemic Treatment of Nonmetastatic Breast Cancer: Facts and Open Questions. The Oncologist. 13(11). 1137–1148. 23 indexed citations
13.
Tampellini, Marco, Alfredo Berruti, Raffaella Bitossi, et al.. (2006). Prognostic significance of changes in CA 15-3 serum levels during chemotherapy in metastatic breast cancer patients. Breast Cancer Research and Treatment. 98(3). 241–248. 29 indexed citations
14.
Fusco, Vittorio, Cinzia Ortega, L. Ciuffreda, et al.. (2006). Bisphosphonates (BP)-related osteonecrosis of the jaw (ONJ): Clinical experience of the “Rete Oncologica di Piemonte e Valle d’Aosta” network. Journal of Clinical Oncology. 24(18_suppl). 18584–18584. 2 indexed citations
15.
Berruti, Alfredo, Raffaella Bitossi, G. Gorzegno, et al.. (2005). Paclitaxel, vinorelbine and 5-fluorouracil in breast cancer patients pretreated with adjuvant anthracyclines. British Journal of Cancer. 92(4). 634–638. 8 indexed citations
16.
Donadio, Michela, Mara Ardine, Alfredo Berruti, et al.. (2005). Weekly Cisplatin plus Capecitabine in Metastatic Breast Cancer Patients Heavily Pretreated with both Anthracycline and Taxanes. Oncology. 69(5). 408–413. 11 indexed citations
17.
Donadio, Michela, et al.. (2004). Pain Control with Zoledronic Acid in Patients with Breast Cancer and Metastatic Bone Disease. 3(4). 257–263. 4 indexed citations
18.
Donadio, Michela, Mara Ardine, Alfredo Berruti, et al.. (2003). Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer: a phase II study. Cancer Chemotherapy and Pharmacology. 52(2). 147–152. 32 indexed citations
19.
Cistaro, Angelina, et al.. (2001). Breast cancer cellular proliferation indexes and 99mTc-sesta Mibi capture: what correlation?. PubMed. 20(1). 91–4. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by L. Ciuffreda Breakdown of academic impact, for papers by Laura Yébenes Breakdown of academic impact, for papers by Georgia Litsas Breakdown of academic impact, for papers by Alberto Dalla Volta Breakdown of academic impact, for papers by Nilesh Mehta Breakdown of academic impact, for papers by Yukinori Ozaki Breakdown of academic impact, for papers by Jean-Jacques Body Breakdown of academic impact, for papers by Anne Sophie Sølling Breakdown of academic impact, for papers by Shinya Maita Breakdown of academic impact, for papers by Victoria Woo
Rankless by CCL
2026